Home > Products > CD19 & CD22
> Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (scFv4-Ig)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-039)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CD19 scFv is fused to the CH1 domain of a heavy chain and another anti-CD22 scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (scFv4-Ig) (FVTIG-039). Click the button below to contact us or submit your feedback about this product.